Getwell Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 105 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), UZPHARM (UZ) and ARCSA (EC). Its GMP standing is certified by CDSCO (India). Customs aggregates show $541K of exports covering 101 molecules to 6 destinations in 2024.
| Site | FDA FEI |
|---|---|
| surat 394 230surat, India | Not on file |
| gurugram, India | Not on file |
| Surat, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 96 | None |
| UZPHARM (UZ) | 8 | None |
| ARCSA (EC) | 1 | None |
| CDSCO (India) | None | 3 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | Not reported | $541K | 6 |
| 2023 | Not reported | $2.3M | 18 |
| 2022 | Not reported | $2.7M | 22 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Getwell Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free